-
1
-
-
84878876242
-
Current therapeutic strategies and novel approaches in osteosarcoma
-
Ando K, Heymann MF, Stresing V, Mori K, Redini F and Heymann D: Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel) 5: 591-616, 2013.
-
(2013)
Cancers (Basel)
, vol.5
, pp. 591-616
-
-
Ando, K.1
Heymann, M.F.2
Stresing, V.3
Mori, K.4
Redini, F.5
Heymann, D.6
-
2
-
-
84879889989
-
New molecular insights into osteosarcoma targeted therapy
-
Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
-
(2013)
Curr Opin Oncol
, vol.25
, pp. 398-406
-
-
Yang, J.1
Zhang, W.2
-
3
-
-
0032929520
-
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
-
Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999.
-
(1999)
Nat Med
, vol.5
, pp. 157-163
-
-
Walczak, H.1
Miller, R.E.2
Ariail, K.3
-
4
-
-
15844412409
-
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
-
Muzio M, Chinnaiyan AM, Kischkel FC, et al: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.
-
(1996)
Cell
, vol.85
, pp. 817-827
-
-
Muzio, M.1
Chinnaiyan, A.M.2
Kischkel, F.C.3
-
5
-
-
84863981709
-
Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma
-
Li C, Cheng Q, Liu J, Wang B, Chen D and Liu Y: Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma. Mol Cell Biochem 364: 337-344, 2012.
-
(2012)
Mol Cell Biochem
, vol.364
, pp. 337-344
-
-
Li, C.1
Cheng, Q.2
Liu, J.3
Wang, B.4
Chen, D.5
Liu, Y.6
-
6
-
-
84872201704
-
Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma
-
Wu J, Zeng T, Wu X, Gao Q, Zhai W and Ding Z: Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma. Cancer Biother Radiopharm 28: 65-70, 2012.
-
(2012)
Cancer Biother Radiopharm
, vol.28
, pp. 65-70
-
-
Wu, J.1
Zeng, T.2
Wu, X.3
Gao, Q.4
Zhai, W.5
Ding, Z.6
-
7
-
-
0035866804
-
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5
-
Mitsiades N, Poulaki V, Mitsiades C and Tsokos M: Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Cancer Res 61: 2704-2712, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 2704-2712
-
-
Mitsiades, N.1
Poulaki, V.2
Mitsiades, C.3
Tsokos, M.4
-
8
-
-
1542466794
-
Critical roles of TRAIL in hepatic cell death and hepatic infammation
-
Zheng SJ, Wang P, Tsabary G and Chen YH: Critical roles of TRAIL in hepatic cell death and hepatic infammation. J Clin Invest 113: 58-64, 2004.
-
(2004)
J Clin Invest
, vol.113
, pp. 58-64
-
-
Zheng, S.J.1
Wang, P.2
Tsabary, G.3
Chen, Y.H.4
-
9
-
-
84881472377
-
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects
-
Miao J, Wu S, Peng Z, Tania M and Zhang C: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol 34: 2093-2098, 2013.
-
(2013)
Tumour Biol
, vol.34
, pp. 2093-2098
-
-
Miao, J.1
Wu, S.2
Peng, Z.3
Tania, M.4
Zhang, C.5
-
10
-
-
68949161794
-
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples
-
He C, Xiong J, Xu X, et al: Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun 388: 35-40, 2009.
-
(2009)
Biochem Biophys Res Commun
, vol.388
, pp. 35-40
-
-
He, C.1
Xiong, J.2
Xu, X.3
-
11
-
-
77953717411
-
Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells
-
Ma L, Liu J, Shen J, et al: Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9: 554-561, 2010.
-
(2010)
Cancer Biol Ther
, vol.9
, pp. 554-561
-
-
Ma, L.1
Liu, J.2
Shen, J.3
-
12
-
-
84887995344
-
Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells
-
Liu J, Ma L, Li C, Zhang Z, Yang G and Zhang W: Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol 7: 1043-1055, 2013.
-
(2013)
Mol Oncol
, vol.7
, pp. 1043-1055
-
-
Liu, J.1
Ma, L.2
Li, C.3
Zhang, Z.4
Yang, G.5
Zhang, W.6
-
13
-
-
84874667309
-
MiRNA-mediated tumor specifc delivery of TRAIL reduced glioma growth
-
Bo Y, Guo G and Yao W: MiRNA-mediated tumor specifc delivery of TRAIL reduced glioma growth. J Neurooncol 112: 27-37, 2013.
-
(2013)
J Neurooncol
, vol.112
, pp. 27-37
-
-
Bo, Y.1
Guo, G.2
Yao, W.3
-
14
-
-
84874218565
-
MicroRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer
-
Zhao Y, Li Y, Wang L, et al: microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer. J Exp Clin Cancer Res 32: 10, 2013.
-
(2013)
J Exp Clin Cancer Res
, vol.32
, pp. 10
-
-
Zhao, Y.1
Li, Y.2
Wang, L.3
-
15
-
-
84880779934
-
Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling
-
Wang B, Liu J, Ma LN, et al: Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling. J Gastroenterol 48: 798-808, 2013.
-
(2013)
J Gastroenterol
, vol.48
, pp. 798-808
-
-
Wang, B.1
Liu, J.2
Ma, L.N.3
-
16
-
-
84878546600
-
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
-
Lou W, Chen Q, Ma L, et al: Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med (Berl) 91: 715-725, 2013.
-
(2013)
J Mol Med (Berl)
, vol.91
, pp. 715-725
-
-
Lou, W.1
Chen, Q.2
Ma, L.3
-
17
-
-
79952668651
-
5/35 fber-modifed conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells
-
He X, Liu J, Yang C, et al: 5/35 fber-modifed conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. Hum Gene Ther 22: 283-292, 2011.
-
(2011)
Hum Gene Ther
, vol.22
, pp. 283-292
-
-
He, X.1
Liu, J.2
Yang, C.3
|